BenevolentAI

BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BioSpace
BenevolentAI
layoffs
Flag link:
BenevolentAI lead atopic dermatitis drug misses the mark
BenevolentAI lead atopic dermatitis drug misses the mark
Pharmaphorum
BenevolentAI
clinical trials
BEN-2293
atopic dermatitis
Flag link:
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
Pharmaforum
BenevolentAI
idiopathic pulmonary fibrosis
AstraZeneca
artificial intelligence
drug development
Flag link:
After nabbing two AI-generated molecules, AstraZeneca returns to BenevolentAI with new collaboration
After nabbing two AI-generated molecules, AstraZeneca returns to BenevolentAI with new collaboration
Endpoints
AstraZeneca
BenevolentAI
machine learning
artificial intelligence
Flag link:
AI-based drug discovery firm BenevolentAI cuts SPAC deal
AI-based drug discovery firm BenevolentAI cuts SPAC deal
Pharmaforum
drug discovery
artificial intelligence
BenevolentAI
SPACs
Europe
Flag link:
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
Pharmaforum
artificial intelligence
machine learning
BenevolentAI
Eli Lilly
olumiant
COVID-19
Flag link:
Benevolent AI and Novartis sign AI R&D deal
Benevolent AI and Novartis sign AI R&D deal
Pharmaforum
Novartis
BenevolentAI
artificial intelligence
oncology
cancer
Flag link:
Artificial Intelligence is Ramping up in Drug Development
Artificial Intelligence is Ramping up in Drug Development
BioSpace
AstraZeneca
drug development
artificial intelligence
BenevolentAI
Flag link:
AZ researches kidney and lung drugs with BenevolentAI
AZ researches kidney and lung drugs with BenevolentAI
Pharmaforum
AstraZeneca
artificial intelligence
R&D
BenevolentAI
Flag link: